A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2011
12/27/2011	US8084424 Compositions and methods related to erythropoietin
12/27/2011	US8084200 Compositions and methods for the diagnosis and treatment of tumor
12/27/2011	US8084041 Use of mycrobacterial vaccines in CD4+ or CD8+ lymphocyte-deficient mammals
12/27/2011	US8084036 Anchoring compound to surface of target cells; protease inhibitors
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/22/2011	US20110312990 Diamine Derivatives
12/22/2011	US20110312987 Salt of naphthyridine carboxylic acid derivative
12/22/2011	US20110312882 Methods and compositions for increasing the anaerobic working capacity in tissues
12/22/2011	US20110311560 Methods and Compositions Relating to CCR5 Antagonist, IFN-Gamma and IL-13 Induced Inflammation
12/22/2011	US20110311500 Combination bacteriolytic therapy for the treatment of tumors
12/22/2011	US20110311462 Compositions for treatment of ear disorders and methods of use thereof
12/22/2011	US20110311442 Direct cellular energy delivery system
12/21/2011	EP2397462A2 Compounds, compositions and methods of treatment for heart failure
12/21/2011	EP2397189A1 Methods of modulating immunity
12/21/2011	EP2397128A1 Use of L-arginine optionally combined with magnesium for the treatment of sickle cell disease and/or pulmonary hypertension
12/21/2011	EP1638551B1 Immunosuppressant compounds and compositions
12/21/2011	CN101486683B 哒嗪酮和三嗪酮化合物及其作为药物制剂的用途 Pyridazinone and triazinone compounds and their use as pharmaceutical preparations
12/20/2011	US8080650 Pro104 antibody compositions and methods of use
12/20/2011	US8080551 HIV inhibiting pyrimidines derivatives
12/20/2011	US8080526 Methods and compositions for the treatment of gastrointestinal disorders
12/20/2011	CA2524409C Androgen receptor modulators and methods of use thereof
12/20/2011	CA2326777C Aminocyclohexyl ether compounds and uses thereof
12/15/2011	US20110306752 Mutant interleukin-2 (il-2) polypeptides
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/14/2011	EP1587479B1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
12/14/2011	EP1532122B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/14/2011	CN1720060B 人乳头瘤病毒多肽和免疫原性组合物 HPV polypeptides and immunogenic compositions
12/14/2011	CN101434574B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/13/2011	US8076361 Form of S-omeprazole
12/13/2011	US8076347 (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine (OddC); "L"-nucleoside that exhibits anti-tumor activity; anticarcinogenic agent for non-small cell lung cancer, colon, breast, prostate, ovarian, CNS, renal, and lymphoma cancer, leukemia, melanoma
12/13/2011	US8076317 administering contraceptives comprising hormones in cycles
12/13/2011	US8075926 Herbal compositions for the treatment of mucosal lesions
12/13/2011	US8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/08/2011	US20110301210 Use of pramipexole to treat amyotrophic lateral sclerosis
12/08/2011	US20110301075 Use of BBI/BBIC for Treatment of Muscular Atrophy and Degenerative Muscle Disease
12/07/2011	EP2392565A1 c-Met modulators and methods of use
12/07/2011	EP2392564A1 c-Met modulators and methods of use
12/07/2011	CN101434573B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/06/2011	USRE43005 Compositions and methods for their preparation from lepidium
12/06/2011	US8071652 Method of treating irritable bowel syndrome
12/06/2011	US8071535 Guanidinium derivatives for improved cellular transport
12/06/2011	US8071321 administering interferon-beta (IFN- beta) receptor agonist and tumor associated antigen to increase an immune response against the tumor cells
12/06/2011	US8071309 Methods for rapid identification of pathogens in humans and animals
12/06/2011	US8071294 Cancer therapy sensitizer
12/06/2011	CA2538748C Cobalamin conjugates for anti-tumor therapy
12/06/2011	CA2515940C Substituted heterocycles
12/06/2011	CA2477748C Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
12/06/2011	CA2380858C Inhibitors of aspartyl protease
12/01/2011	US20110294902 Pharmaceutical compositions providing enhanced drug concentrations
12/01/2011	US20110294889 Infusion and Injection Solution of Levodopa
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110293707 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
11/2011
11/30/2011	EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
11/30/2011	EP2390262A1 Synthetic chemokine receptor ligands and methods of use thereof
11/30/2011	EP1633372B1 Vaccines, immunotherapeutics and methods for using the same
11/30/2011	EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists
11/30/2011	CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions
11/29/2011	US8067600 Histone deacetylase inhibitors and methods of use thereof
11/29/2011	US8067436 c-Met modulators and methods of use
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067381 Methods and compositions for increasing the anaerobic working capacity in tissues
11/29/2011	US8067371 Receptor for Advanced Glycation Endproducts (RAGE); rheumatoid arthritis; solubility
11/29/2011	US8067181 MELKS as modifiers of the Rac pathway and methods of use
11/29/2011	US8067059 Hydrophobic composites and particulates and applications thereof
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/29/2011	CA2479786C Quinoline derivatives and their use as 5-ht6 ligands
11/29/2011	CA2448208C Influenza vaccine composition
11/24/2011	US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288056 Once daily formulations of tetracyclines
11/23/2011	EP2387998A1 Methods for treating degenerative diseases/injuries
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/22/2011	US8063183 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8062654 Drug releasing biodegradable fiber for delivery of therapeutics
11/22/2011	US8062634 Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor
11/22/2011	US8062626 Ethanolic solutions; shelf life; nebulizer metering device; free of ozone damaging materials
11/22/2011	CA2519172C Phosphoric ester demulsifier composition
11/22/2011	CA2513655C Use of tryptanthrin compounds for immune potentiation
11/22/2011	CA2489730C Use of mglur5 antagonists for the treatment of gerd
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/17/2011	US20110282360 ROBOTIC ARMS DLUs FOR PERFORMING SURGICAL TASKS
11/15/2011	US8058443 making crystalline lenalidomide
11/15/2011	US8058424 Synthesis of 5-azacytidine
11/15/2011	US8058396 Cystatin C as an antagonist of TGF-β and methods related thereto
11/15/2011	US8058254 DNA vaccines encoding heat shock proteins
11/15/2011	US8058234 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	CA2548089C A low-weight ultra-thin flexible radiation attenuation composition
11/15/2011	CA2318392C Mammalian appeasing pheromones to decrease stress, anxiety and aggressiveness
11/10/2011	US20110274669 Therapeutic retroviral vectors for gene therapy
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1663103B1 Compositions of botanical extracts for cancer therapy

1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 295